We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$100B
AUM Growth
-$15.7B
Cap. Flow
-$21.7B
Cap. Flow %
-21.63%
Top 10 Hldgs %
15.09%
Holding
3,879
New
490
Increased
1,152
Reduced
1,671
Closed
544

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$276M
2
PG icon
Procter & Gamble
PG
+$243M
3
ADI icon
Analog Devices
ADI
+$188M
4
AMD icon
Advanced Micro Devices
AMD
+$171M
5
HD icon
Home Depot
HD
+$162M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.95B
2
BMY icon
Bristol-Myers Squibb
BMY
+$778M
3
WMT icon
Walmart Inc
WMT
+$723M
4
ZM icon
Zoom
ZM
+$642M
5
CMG icon
Chipotle Mexican Grill
CMG
+$573M

Sector Composition

Rank Sector Weight
1 Healthcare 22.93%
2 Technology 16.65%
3 Consumer Staples 12.19%
4 Consumer Discretionary 9.52%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOL
3776
DELISTED
Biolase, Inc.
BIOL
-218
Closed -$252K
SCPX
3777
DELISTED
Scorpius Holdings, Inc.
SCPX
-108
Closed -$2.56M
AVGR
3778
DELISTED
Avinger, Inc. Common Stock
AVGR
-1,653
Closed -$153K
MRNS
3779
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-10,950
Closed -$111K
GENE
3780
DELISTED
Genetic Technologies Ltd.
GENE
-21,233
Closed -$242K
SOLO
3781
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
-148,334
Closed -$334K
NSTG
3782
DELISTED
NanoString Technologies, Inc.
NSTG
-68,100
Closed -$2M
DMK
3783
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-244
Closed -$9K
GOL
3784
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-452,200
Closed -$3.07M
NETI
3785
DELISTED
Eneti Inc.
NETI
-32,289
Closed -$494K
CYTO
3786
DELISTED
Altamira Therapeutics Ltd
CYTO
-143
Closed -$54K
RAD
3787
DELISTED
Rite Aid Corporation
RAD
-738,490
Closed -$12.6M
RETA
3788
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-134,700
Closed -$21M
BLU
3789
DELISTED
BELLUS Health Inc.
BLU
-65,438
Closed -$677K
CYAD
3790
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
-10,300
Closed -$110K
DTEA
3791
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
-129,549
Closed -$124K
AGRX
3792
DELISTED
Agile Therapeutics
AGRX
-72
Closed -$401K
OBSV
3793
DELISTED
ObsEva SA Ordinary Shares
OBSV
-221,500
Closed -$1.3M
TMDI
3794
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
-34,645
Closed -$29K
TCDA
3795
DELISTED
Tricida, Inc. Common Stock
TCDA
-160,717
Closed -$4.42M
ZEN
3796
DELISTED
ZENDESK INC
ZEN
-6,000
Closed -$531K
PHAS
3797
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-131,500
Closed -$605K
USWS
3798
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
-1,615
Closed -$17K
CCXI
3799
DELISTED
ChemoCentryx, Inc.
CCXI
-265,100
Closed -$15.3M
GBT
3800
DELISTED
Global Blood Therapeutics, Inc.
GBT
-50,400
Closed -$3.18M

Similar funds

Renaissance Technologies's Q3 2020 Portfolio in Review

As of Q3 2020, Renaissance Technologies held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Renaissance Technologies withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Renaissance Technologies opened a new position in Microsoft worth $277M.

  • Renaissance Technologies's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
  • Renaissance Technologies added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
  • Renaissance Technologies's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
  • Renaissance Technologies fully exited Alibaba in Q3 2020, selling an estimated $426M.
  • Renaissance Technologies's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
  • Renaissance Technologies opened 490 new positions and closed 544 in Q3 2020.
  • Renaissance Technologies's portfolio value fell 14% quarter-over-quarter to $100B.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.